Hebb, M O <br/><br/>
End-capped antisense oligodeoxynucleotides effectively inhibit gene expression in vivo and offer a low-toxicity alternative to fully modified phosphorothioate oligodeoxynucleotides.  [electronic resource] 

 -  Brain research. Molecular brain research  Jul 1997 
 - 223-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0169-328X 
<br/><br/><label>Standard No.: </label>10.1016/s0169-328x(97)00048-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Behavior, Animal--drug effects<br/>Corpus Striatum--drug effects<br/>Gene Expression--drug effects<br/>Immunohistochemistry<br/>Male<br/>Oligonucleotides--pharmacology<br/>Oligonucleotides, Antisense--pharmacology<br/>Proto-Oncogene Proteins c-fos--drug effects<br/>Rats<br/>Rats, Sprague-Dawley